Balance Sheet Data

KalVista Pharmaceuticals, Inc. (KALV)

$8.97

+0.03 (+0.00%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 100.8167.71248.93166.20149.3882.6765.0551.1940.2831.70
Total Cash (%)
Account Receivables 11.3116.5310.4214.1016.577.856.174.863.823.01
Account Receivables (%)
Inventories ---2.712.131.681.321.040.820.64
Inventories (%)
Accounts Payable 2.861.681.983.644.821.781.401.100.870.68
Accounts Payable (%)
Capital Expenditure -1.08-0.22-0.08-0.93-1.20-0.42-0.33-0.26-0.20-0.16
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.